<p>Treatment results in children with acute lymphoblastic leukemia (ALL) treating in St.-Petersburg hospitals according to two modified version of German protocol CO ALL-92 from 01.01.1993 to 01.01.2007 are presented. 438 primary A LL patients aged from 4 months to 17 year s have been included in the study . ALL diagnosed according to international criteria. Based on prognostic factors patients were a llocated to one of two risk groups, which determined therapy intensity . The total treatment duration in both groups w as 2 years and consist ed of 5.5–8 months intensive phase with subsequent maintenance therapy . A comparative treatment results analysis in children with A LL according to two modified versions of COALL-92 is presented.</p
Background. From 1991 until 2004 children with acute lymphoblastic leukemia (ALL) in the Netherlands...
Background Lymphoblastic lymphoma (LBL) is the second most frequent lymphoma subtype in childhood. I...
16 years of age) with de novo acute lymphoblastic leukemia (ALL) were treated according to protocol ...
<em>Regardless the success gained in treatment of acute lymphoblastic leukaemia, several problems st...
The article presents the results of the treatment of children with acute lymphoblast leukemia (all) ...
SummaryBackgroundAcute lymphoblastic leukaemia (ALL) represents about 30% of cancer in children and ...
Treatment of acute lymphoblastic leukemia (ALL) in children during the last 50 years has changed sig...
Background and objective: Because of the need for more comprehensive information on the least toxic ...
Artículo de publicación ISIPurpose From 2002 to 2007, the International Berlin-Frankfurt-Mu¨ nster ...
The purpose of our research was the estimation of results of treatment of childhood acute lymphoblas...
The cure rate of acute lymphoblastic leukemia (ALL) in children dramatically improved over past 5 de...
The article demonstrates the treatment results on the protocol the treatment of children with acute ...
Dramatic progress in the treatment of childhood acute lymphoblastic leukemia (ALL) has been achieved...
Despite intensified chemotherapy, adolescents with acute lymphoblastic leukemia (ALL) still have low...
We analyzed the long-term outcome of 4865 patients treated in Studies 82, 87, 88, 91 and 95 for chil...
Background. From 1991 until 2004 children with acute lymphoblastic leukemia (ALL) in the Netherlands...
Background Lymphoblastic lymphoma (LBL) is the second most frequent lymphoma subtype in childhood. I...
16 years of age) with de novo acute lymphoblastic leukemia (ALL) were treated according to protocol ...
<em>Regardless the success gained in treatment of acute lymphoblastic leukaemia, several problems st...
The article presents the results of the treatment of children with acute lymphoblast leukemia (all) ...
SummaryBackgroundAcute lymphoblastic leukaemia (ALL) represents about 30% of cancer in children and ...
Treatment of acute lymphoblastic leukemia (ALL) in children during the last 50 years has changed sig...
Background and objective: Because of the need for more comprehensive information on the least toxic ...
Artículo de publicación ISIPurpose From 2002 to 2007, the International Berlin-Frankfurt-Mu¨ nster ...
The purpose of our research was the estimation of results of treatment of childhood acute lymphoblas...
The cure rate of acute lymphoblastic leukemia (ALL) in children dramatically improved over past 5 de...
The article demonstrates the treatment results on the protocol the treatment of children with acute ...
Dramatic progress in the treatment of childhood acute lymphoblastic leukemia (ALL) has been achieved...
Despite intensified chemotherapy, adolescents with acute lymphoblastic leukemia (ALL) still have low...
We analyzed the long-term outcome of 4865 patients treated in Studies 82, 87, 88, 91 and 95 for chil...
Background. From 1991 until 2004 children with acute lymphoblastic leukemia (ALL) in the Netherlands...
Background Lymphoblastic lymphoma (LBL) is the second most frequent lymphoma subtype in childhood. I...
16 years of age) with de novo acute lymphoblastic leukemia (ALL) were treated according to protocol ...